Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,828,942
  • Shares Outstanding, K 314,363
  • Annual Sales, $ 2,794 M
  • Annual Income, $ -116,890 K
  • EBIT $ 358 M
  • EBITDA $ 623 M
  • 60-Month Beta 1.36
  • Price/Sales 1.35
  • Price/Cash Flow 8.64
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 119.56% (-1.07%)
  • Historical Volatility 38.98%
  • IV Percentile 94%
  • IV Rank 74.53%
  • IV High 159.57% on 09/19/25
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 14) 0.19 (1.57%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 46
  • Volume Avg (30-Day) 201
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 10,750
  • Open Int (30-Day) 9,772
  • Expected Range 11.75 to 12.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.16
  • Number of Estimates 2
  • High Estimate 0.18
  • Low Estimate 0.14
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.14 +7.14%
on 11/05/25
12.68 -5.84%
on 11/28/25
+0.59 (+5.20%)
since 11/04/25
3-Month
9.44 +26.55%
on 09/05/25
12.68 -5.84%
on 11/28/25
+2.39 (+25.03%)
since 09/04/25
52-Week
6.68 +78.74%
on 04/10/25
12.68 -5.84%
on 11/28/25
+3.13 (+35.53%)
since 12/04/24

Most Recent Stories

More News
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

JAZZ : 166.91 (-0.11%)
AZTA : 35.10 (-1.40%)
AMRX : 11.94 (-1.97%)
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has...

AMRX : 11.94 (-1.97%)
Amneal to Participate in Upcoming Investor Conferences

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, and Tasos Konidaris, Chief Financial...

AMRX : 11.94 (-1.97%)
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

Approval underscores Amneal’s advanced sterile manufacturing capabilities and expansion within complex ophthalmic therapies; Launch expected in Q1 2026  BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE...

AMRX : 11.94 (-1.97%)
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

NTRA : 242.06 (+1.62%)
CHE : 424.30 (-1.52%)
PNTG : 28.94 (-0.48%)
HCA : 487.66 (+0.18%)
AMRX : 11.94 (-1.97%)
Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks

Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks

AMRX : 11.94 (-1.97%)
3 Russell 2000 Stocks with Warning Signs

3 Russell 2000 Stocks with Warning Signs

TENB : 26.65 (-0.60%)
AMRX : 11.94 (-1.97%)
HOPE : 10.93 (-0.09%)
Amneal Receives U.S. FDA Approval for Iohexol Injection

BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved...

AMRX : 11.94 (-1.97%)
3 Stocks Under $50 We Steer Clear Of

3 Stocks Under $50 We Steer Clear Of

WAFD : 32.20 (+0.19%)
AMTM : 29.25 (+2.42%)
AMRX : 11.94 (-1.97%)
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

JAZZ : 166.91 (-0.11%)
BDX : 193.76 (+0.10%)
AMRX : 11.94 (-1.97%)
PFE : 25.70 (+0.51%)
DVA : 117.28 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 12.71
2nd Resistance Point 12.47
1st Resistance Point 12.20
Last Price 11.94
1st Support Level 11.69
2nd Support Level 11.45
3rd Support Level 11.18

See More

52-Week High 12.68
Last Price 11.94
Fibonacci 61.8% 10.39
Fibonacci 50% 9.68
Fibonacci 38.2% 8.97
52-Week Low 6.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar